What happens if a safety issue is identified after a vaccine is approved?
If a safety issue is identified after a vaccine is approved, the FDA can take several actions to protect public health. These may include updating the product’s label with new safety information, issuing warnings, restricting the product’s use, or in extreme cases, withdrawing the vaccine from the market. The FDA works closely with healthcare providers and other stakeholders to monitor and manage any potential risks.
